營養與生活 中英對照

維生素 D 對健康的影響:缺乏標準、研究發現與補充建議

Role of Vitamin D in Health and Disease and Supplementation

作者:Menaf(國際健康諮詢顧問) 中文編譯:日安健康 閱讀時間:約 8 分鐘

重點摘要

  1. 維生素 D 主要靠皮膚曬太陽合成,也可從魚類、蛋黃與強化食品攝取,經肝臟、腎臟轉換成活性形式。
  2. 血中 25(OH)D 低於 20 ng/mL 為缺乏,低於 30 ng/mL 為不足。
  3. 研究發現維生素 D 濃度與跌倒、骨折、心血管與部分癌症風險有關,但多為觀察性研究;補充劑量應在檢測後由醫師建議。
本文目錄
  1. 維生素 D 在體內的轉換
  2. 缺乏與不足的標準
  3. 維生素 D 對健康的影響:研究摘要
  4. 補充建議
  5. 參考文獻
  6. 什麼情況該就醫?
  7. 日安健康怎麼評估

維生素 D 是一群脂溶性的荷爾蒙,對維持骨骼與肌肉健康至關重要,也與腎臟以外的組織、大腦功能、免疫、懷孕、癌症預防與心血管健康有關。除了從食物攝取,例如脂肪豐富的魚、魚肝油、蛋黃、波特菇、牛肝,以及早餐穀片、牛奶(含乳與非乳製品)、嬰兒配方奶、起司等強化食品,人體所需的維生素 D,有相當大一部分是靠皮膚接受陽光中的紫外線 B(UVB)合成。維生素 D 有兩種形式:維生素 D2(麥角鈣化醇)與 D3(膽鈣化醇)。

Vitamin D is a group of fat-soluble hormones that is vital for the maintenance of bone and muscle health. It is also vital for extra-renal tissues, brain function, immunity, pregnancy, cancer prevention, and cardiovascular health. In addition to food sources such as fatty fish, cod liver oil, egg yolks, portabella mushrooms, beef liver, and fortified foods such as breakfast cereal, milk (dairy and nondairy), infant formula and cheese, the human body uses ultraviolet B (UVB) radiation from sunlight to synthesize a significant portion of its vitamin D requirements. There are two forms of vitamin D: vitamin D2 (ergocalciferol) and D3 (cholecalciferol).

維生素 D 在體內的轉換Vitamin D metabolism

陽光 UVB → 皮膚 7-脫氫膽固醇 → 維生素 D3 飲食攝取 維生素 D2、D3 肝臟 Liver 25(OH)D|血中主要形式 腎臟 Kidney 1,25(OH)₂D|活性形式 抽血檢測的是 25(OH)D,用來判斷維生素 D 是否足夠
維生素 D 在體內的轉換(日安健康依原文重繪)|Vitamin D metabolism, redrawn from the original text

皮膚中的 7-脫氫膽固醇照射到陽光中的 UVB(波長 290–320 nm)後,會轉換成維生素 D3 前驅物(previtamin D3),再經由受熱的過程立即轉換成維生素 D。來自日曬與飲食的維生素 D2 與 D3 進入肝臟後,會轉換成 25-羥基維生素 D〔25(OH)D〕。25(OH)D 是血液中維生素 D 的主要形式,也是用來判斷維生素 D 狀態的指標。接著,25(OH)D 由維生素 D 結合蛋白(DBP)運送到腎臟,經 1α-羥化酶作用,形成具有荷爾蒙活性的 1,25-二羥基維生素 D〔1α,25(OH)2D〕。

Vitamin D3 is formed when 7-dehydrocholesterol in the skin is exposed to solar ultraviolet B (UVB, 290–320 nm) and converted to previtamin D3. In a heat-dependent process, previtamin D3 is immediately converted to vitamin D. Vitamin D2 and D3 resulting from exposure to sunlight and the diet are converted to 25-hydroxyvitamin D [25(OH)D] when they enter the liver. 25(OH)D is the major circulating form of vitamin D and is used to determine vitamin D status. Then, 25(OH)D is carried by DBP to the kidney, where hydroxylation by 1α-hydroxylase to 1,25-dihydroxyvitamin D [1α,25(OH)2D] occurs, producing the hormonally active form of vitamin D.

缺乏與不足的標準Deficiency and insufficiency

血清 25(OH)D 低於 20 ng/mL 屬於維生素 D 缺乏,低於 30 ng/mL(75 nmol/L)屬於不足;而 30–44 ng/mL 對肌肉骨骼、免疫、心血管健康與癌症等結果最有益。每天多補充 100 IU 的維生素 D,血清 25(OH)D 預期約上升 1 ng/mL(2.5 nmol/L)。25(OH)D 偏低,會增加多種慢性疾病、高血壓、糖尿病與癌症的風險。

Vitamin D deficiency is defined as a serum 25(OH)D level below 20 ng/mL and vitamin D insufficiency as less than 30 ng/mL (75 nmol/L), while a 25(OH)D level of 30–44 ng/mL provides optimal benefits for outcomes in musculoskeletal health, immunity, cardiovascular health and cancer. Serum 25(OH)D can be expected to rise by about 1 ng/mL (2.5 nmol/L) for every 100 IU of additional vitamin D each day. The consequences of low 25(OH)D status include increased risk of various chronic diseases, hypertension, diabetes and cancer.

維生素 D 對健康的影響:研究摘要Summary of health effects of vitamin D

項目研究發現Findings (original)
肌肉骨骼健康Musculoskeletal health
  • 每天 700–1000 IU 維生素 D,讓年長者跌倒風險降低 19%
  • 每天 482–770 IU,讓非脊椎骨折減少 20%、髖部骨折減少 18%
  • 700–1000 IU of vitamin D daily reduced fall risk in elderly patients by 19%
  • 482–770 IU of vitamin D daily reduced non-vertebral fractures by 20% and hip fractures by 18%
多發性硬化症Multiple sclerosis
  • 在白人患者中,血清 25(OH)D 越高,罹患多發性硬化症的風險顯著越低
  • In white patients, the risk of MS was significantly decreased with increasing serum 25(OH)D levels
糖尿病Diabetes
  • 血清 25(OH)D 與口服葡萄糖耐受試驗中的胰島素、血糖濃度呈負相關
  • 每天 700 IU 維生素 D3 加 500 mg 鈣、與安慰劑比較三年,補充組空腹血糖的上升幅度與胰島素阻抗的增加都較少
  • Serum levels of 25(OH)D were inversely correlated with serum insulin levels and glucose concentrations during an oral glucose tolerance test
  • 700 IU of vitamin D3 plus 500 mg of calcium daily vs. placebo found a lower overall rise in fasting blood glucose levels and a lower increase in insulin resistance over a three-year period in the treatment group
心血管健康Cardiovascular health
  • 25(OH)D ≤ 15 ng/mL 的男性,心肌梗塞風險高於 ≥ 30 ng/mL 者
  • 血清 25(OH)D 在最低兩個四分位(7.6 與 13.3 ng/mL)的患者,全死因與心血管死亡率都高於最高四分位(28.4 ng/mL)
  • 基礎維生素 D 偏低,可能與較高的心血管與腦血管死亡風險有關
  • Men with 25(OH)D levels ≤15 ng/mL had an increased risk for myocardial infarction (MI) compared with those with ≥30 ng/mL
  • Patients in the lower two quartiles of serum 25(OH)D levels (7.6 and 13.3 ng/mL) had higher all-cause and cardiovascular mortality compared with the highest quartile (28.4 ng/mL)
  • A relationship between low vitamin D levels at baseline and a higher risk of cardiovascular and cerebrovascular death may exist
免疫Immunity
  • 1,25(OH)2D 會誘導 cathelicidin 等抗菌胜肽
  • 在結核病標準治療中加入維生素 D 補充,效果優於單用標準治療
  • 1,25(OH)2D induces cathelicidins and other anti-microbial peptides
  • Addition of vitamin D supplementation to tuberculosis treatment regimens was superior to standard treatment alone
大腸直腸癌Colorectal cancer
  • 25(OH)D 較高的大腸直腸癌患者,與較低者相比,全死因死亡風險低 29%、大腸直腸癌死亡風險低 35%
  • CRC patients with high 25(OH)D levels had 29% and 35% lower risk of dying from any cause or from CRC, respectively, compared to those with low 25(OH)D levels
胰臟癌Pancreatic cancer
  • 每天攝取 ≥ 600 IU 維生素 D,與較低的胰臟癌風險相關
  • Intake of vitamin D ≥600 IU/day was associated with a lower risk for pancreatic cancer
消化道癌症Gastrointestinal cancer
  • 血清 25(OH)D 每增加 25 nmol/L,消化系統癌症死亡率降低 45%
  • Incremental increase of serum 25(OH)D by 25 nmol/L was associated with a 45% decrease in digestive system cancer mortality
乳癌Breast cancer
  • 血清 25(OH)D 最高與最低五分位相比,乳癌發生率降低 30%
  • A 30% decrease in breast cancer incidence was observed between the highest and lowest quintiles of serum 25(OH)D levels
所有癌症發生率All cancer incidence
  • 血清 25(OH)D 每增加 25 nmol/L,癌症總發生率降低 17%
  • Incremental increase of serum 25(OH)D by 25 nmol/L was associated with a 17% reduction in total cancer incidence
所有癌症死亡率All cancer mortality
  • 血清 25(OH)D 每增加 25 nmol/L,癌症總死亡率降低 29%
  • Incremental increase of serum 25(OH)D by 25 nmol/L was associated with a 29% decrease in all cancer mortality

編者註

表中多數為觀察性研究,呈現的是「血中維生素 D 濃度與疾病風險的關聯」,不代表補充維生素 D 就能預防或治療這些疾病。例如大型隨機試驗 VITAL 研究顯示,補充維生素 D 並未降低癌症發生率。維生素 D 是維持健康的一環,不能取代癌症篩檢與疾病治療。

補充建議Supplementation

美國國家醫學院(Institute of Medicine)建議,1 至 70 歲的多數人每天攝取 600 IU 維生素 D。

The majority of people between the ages of 1 and 70 should consume 600 IU of vitamin D daily, according to the Institute of Medicine.

70 歲以上、日曬很少的人,每天可能需要 800 IU。美國內分泌學會建議成人每天 1500–2000 IU、兒童 1000 IU。對於缺乏的人,維生素 D 應與鈣一起補充,以維持骨骼健康。

Those older than 70 years may need 800 IU per day, assuming minimal sun exposure. The Endocrine Society recommends 1500 to 2000 IU per day for adults and 1000 IU for children. Vitamin D should be given with calcium to maintain bone health in those who are deficient.

所有經檢測確認缺乏維生素 D 的成人,都應接受治療:每週 50,000 IU 維生素 D3,或每天 6000 IU,持續 8 週,使血清 25(OH)D 達到 30 ng/mL,之後再以維持劑量補充。美國內分泌學會的指引支持這項建議,並補充:1–18 歲可能需要每天 1000 IU、19–50 歲可能需要每天 1500–2000 IU 的維持劑量,才能讓血清 25(OH)D 穩定維持在 30 ng/mL 以上。

All adults found to be vitamin D deficient should be treated with either 50,000 IU of vitamin D3 per week or 6000 IU per day for 8 weeks to achieve a serum 25(OH)D level of 30 ng/mL. Treatment should be followed by a maintenance dose. The Endocrine Society's guidelines support this recommendation but add that a maintenance dose of 1000 IU per day may be needed to consistently raise serum 25(OH)D levels above 30 ng/mL in patients aged 1 to 18 years and as much as 1500 to 2000 IU per day in patients aged 19 to 50 years.

美國兒科醫學會建議,所有兒童從出生後數天起直到青春期,每天攝取 400 IU 維生素 D。

The American Academy of Pediatrics recommends that all children receive 400 IU per day of vitamin D from their first few days of life through adolescence.

編者註

以上為美國的建議。台灣衛福部「國人膳食營養素參考攝取量」(第八版)建議:50 歲以下每天 10 微克(400 IU)、51 歲以上每天 15 微克(600 IU),成人每日上限攝取量為 50 微克(2000 IU)。文中治療缺乏的高劑量(例如每週 50,000 IU)屬於醫療處置,必須經抽血確認、由醫師開立並監測,請勿自行服用;維生素 D 過量可能造成高血鈣、腎結石等問題。

參考文獻References

  1. Heaney, R. P. (2008). Vitamin D in health and disease. Clinical Journal of the American Society of Nephrology, 3(5), 1535–1541. https://doi.org/10.2215/cjn.01160308
  2. Basit, S. (2013). Vitamin D in health and disease: a literature review. British Journal of Biomedical Science, 70(4), 161–172. https://doi.org/10.1080/09674845.2013.11669951
  3. LoPiccolo, M. C., & Lim, H. W. (2010). Vitamin D in health and disease. Photodermatology Photoimmunology & Photomedicine, 26(5), 224–229. https://doi.org/10.1111/j.1600-0781.2010.00524.x
  4. Pfotenhauer, Kim M. and Shubrook, Jay H. "Vitamin D Deficiency, Its Role in Health and Disease, and Current Supplementation Recommendations" Journal of Osteopathic Medicine, vol. 117, no. 5, 2017, pp. 301-305. https://doi.org/10.7556/jaoa.2017.055
  5. Zmijewski, M.A. Vitamin D and Human Health. Int. J. Mol. Sci. 2019, 20, 145. https://doi.org/10.3390/ijms20010145
  6. Souberbielle, J., Body, J., Lappe, J. M., Plebani, M., Shoenfeld, Y., Wang, T. J., Bischoff-Ferrari, H. A., Cavalier, E., Ebeling, P. R., Fardellone, P., Gandini, S., Gruson, D., Guérin, A. P., Heickendorff, L., Hollis, B. W., Ish-Shalom, S., Jean, G., Von Landenberg, P., Largura, A., . . . Zittermann, A. (2010). Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmunity Reviews, 9(11), 709–715. https://doi.org/10.1016/j.autrev.2010.06.009
  7. Bischoff-Ferrari, H. (2009). Vitamin D: What is an adequate vitamin D level and how much supplementation is necessary? Best Practice & Research Clinical Rheumatology, 23(6), 789–795. https://doi.org/10.1016/j.berh.2009.09.005
  8. Wang S. Epidemiology of vitamin D in health and disease. Nutrition Research Reviews. 2009;22(2):188-203. doi:10.1017/S0954422409990151
  9. Holick, M. F. (2008). Vitamin D and sunlight. Clinical Journal of the American Society of Nephrology, 3(5), 1548–1554. https://doi.org/10.2215/cjn.01350308
  10. Baeke F, Etten EV, Overbergh L, Mathieu C. Vitamin D3 and the immune system: maintaining the balance in health and disease. Nutrition Research Reviews. 2007;20(1):106-118. doi:10.1017/S0954422407742713
  11. Pappa, H. M., Grand, R. J., & Gordon, C. M. (2006). Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflammatory Bowel Diseases, 12(12), 1162–1174. https://doi.org/10.1097/01.mib.0000236929.74040.b0
  12. Pilz, S., Tomaschitz, A., März, W., Drechsler, C., Ritz, E., Zittermann, A., Cavalier, E., Pieber, T. R., Lappe, J. M., Grant, W. B., Holick, M. F., & Dekker, J. M. (2011). Vitamin D, cardiovascular disease and mortality. Clinical Endocrinology, 75(5), 575–584. https://doi.org/10.1111/j.1365-2265.2011.04147.x

什麼情況該就醫?

  • 很少曬太陽,或長時間待在室內
  • 骨質疏鬆、容易跌倒或骨折
  • 肌肉無力、全身痠痛、容易疲倦
  • 長期自行補充高劑量維生素 D,想確認是否過量

日安健康怎麼評估?

日安健康可以檢測血中 25(OH)D 濃度,依結果、年齡與用藥狀況,由醫師與營養師建議日曬、飲食與補充劑量,並定期追蹤。

本文為衛教資訊,不能取代醫師診斷與治療。若有身體不適,請尋求醫療專業協助。各項檢測與治療需經醫師評估,效果因人而異。
英文原文由本院國際健康諮詢顧問 Menaf 撰寫(Menaf 未具中華民國醫師證書,不在台灣執行診斷與治療);中文由日安健康編譯,「編者註」為日安健康補充的說明與台灣相關建議。

LINE 詢問 前往預約